RT Journal Article
SR Electronic
T1 Iohexol versus metrizamide for cervical myelography: double-blind trial.
JF American Journal of Neuroradiology
JO Am. J. Neuroradiol.
FD American Society of Neuroradiology
SP 923
OP 926
VO 6
IS 6
A1 S S Gebarski
A1 T O Gabrielsen
A1 J E Knake
A1 J T Latack
A1 P J Yang
A1 J T Hoff
YR 1985
UL http://www.ajnr.org/content/6/6/923.abstract
AB Cervical myelography was performed by lateral C1-C2 puncture in 60 patients. Thirty patients received iohexol (an investigational aqueous contrast agent) and 30 received metrizamide in order to provide a prospective, randomized, double-blind trial comparing these contrast media. The two media produced radiographs of equal quality. Contrast-related morbidity was suffered by four patients (13%) in the iohexol group and by 11 patients (37%) in the metrizamide group. These features indicate that iohexol is superior to metrizamide as a contrast agent for cervical myelography.